Yunbei Xiao

518 citations
40 papers · 411 indexed · h-index 11
Topics
Cancer, Lipids, and Metabolism (6 papers)Chemokine receptors and signaling (5 papers)Bladder and Urothelial Cancer Treatments (4 papers)

In The Last Decade

Yunbei Xiao

35 papers receiving 398 citations

Peers

Yunbei Xiao
Comparison fields: 5 of 83
  • Molecular Biology 114
  • Oncology 77
  • Pharmacology 76
  • Cancer Research 71
  • General Health Professions 68
Replace Xuebiao Peng with:
Xuebiao Peng China
Gangyu Zhang China
Hongfeng Zhou China
Friederike Hoellen Germany
Xingjie Wang China
Hanqing Zeng China
Larisa Prpić Massari Croatia
Wujiang Liu China
Lin Luo China
Yunbei Xiao relative to Xuebiao Peng China Xuebiao Peng's profile →
Citations per field
00.5×5.5×
Xuebiao Peng · 1×
Citations per year

Countries citing papers authored by Yunbei Xiao

Since Specialization
Citations

This map shows the geographic impact of Yunbei Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunbei Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunbei Xiao more than expected).

Fields of papers citing papers by Yunbei Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunbei Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunbei Xiao. The network helps show where Yunbei Xiao may publish in the future.

Co-authorship network of co-authors of Yunbei Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Yunbei Xiao. A scholar is included among the top collaborators of Yunbei Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunbei Xiao. Yunbei Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 8
5 1
6 2
7 1
8 1
9 0
10 3
11 1
12 2
13 4
14 28
15
[Free fatty acids induce proliferation of human renal carcinoma 786-O cell line via integrin-linked kinase].
1
16 31
17 9
18 22
19
[CMTM5 inhibits the tumor cell behavior of prostate cancer by downregulation of HER2].
5
20 80

About Yunbei Xiao

Yunbei Xiao is a scholar working on Urology, Cancer Research and Physiology, having authored 40 papers that have together received 411 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (6 papers), Chemokine receptors and signaling (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Cancer Research (71 citations), Pharmacology (76 citations) and Urology (28 citations). Yunbei Xiao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaowei Zhang, Yeqing Yuan, Zhigang Wu, Zhenhua Liu, Tao Xu, Jinguo Wang, Zong-Qi Liang, Wenbin Wan, Zhiliang Weng and Jian‐Hui Xiao. Their work appears in journals such as PLoS ONE, Journal of Cell Science and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026